AFASCI, INC.

AFASCI, INC. is a biotech company in Burlingame, United States, founded in 2015. It has raised $12.8M across 9 rounds, most recently a $983K Grant in September 2023.

AfaSci

Employees
1–10
Founded
2015
Website
afasci.com
Total Funding
$12.8M
Last Round
$983K GrantSep 2023
Rounds
9

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 9 funding rounds and 1 investor for this company. The full record is or through the API.

About

AfaSci, Inc. is a San Francisco Bay Area biopharmaceutical company with active collaborations with academic institutions including Stanford University, Harvard University, UCLA, UC Davis, and Kansas State University. The company leverages a proprietary drug discovery platform for more effective target identification and efficient animal testing, in vivo pharmacology, and electrophysiology studies. AfaSci is now looking to accelerate IND-enabling studies for its two neuropathic and neuroinflammatory pain therapeutic candidates, and seeking opportunities with potential investors and business partners.

Summary

It lists 1–10 employees. It has raised $12.8M in total across 9 rounds, most recently a $983K Grant round in Sep 2023. Investors include National Institutes of Health.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
GrantSBIR Phase I (NIH)Sep 2023
$983K

Sign up to see all 9 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AFASCI, INC. on Indexed.vc
<a href="https://indexed.vc/companies/afasci-inc"><img src="https://indexed.vc/api/badge/company/afasci-inc" alt="AFASCI, INC. on Indexed.vc" width="260" height="76" /></a>